Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Egeberg

Showing results (31-40 of 331) with videos related to

Pageof 34
Sort By:
The British Journal of Dermatology|February 2, 2022
Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapyMette Gyldenløve, Howraman Meteran, Claus Zachariae, et al.
JAMA Dermatology|February 20, 2020
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysisSofie Vaengebjerg, Lone Skov, Alexander Egeberg, et al.
BMJ Open|March 23, 2019
Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohortAlexander Egeberg, Yuki M F Andersen, Jacob P Thyssen
Case Reports in Dermatology|April 1, 2021
Subtype-Specific Off-Label Treatment of RosaceaNita Wienholtz, Messoud Ashina, Jacob P Thyssen, et al.
Pharmacoepidemiology and Drug Safety|November 27, 2024
Post-Marketing Safety of Ustekinumab Based on 14-Year Follow-Up in Danish National Patient DataSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
International Journal of Pharmaceutical Compounding|March 21, 2020
Low-dose Naltrexone Therapy for PsoriasisLeonard B Weinstock, Jill Cottel, Lindsey Aldridge, et al.
Journal of the American Academy of Dermatology|July 31, 2020
Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysisNikolai Loft, Anne-Sofie Halling, Alexander Egeberg, et al.
Pharmacoepidemiology and Drug Safety|January 29, 2026
Comparing Different As-Treated Approaches: A Methodological Study Using Real-World Data on Psoriasis TreatmentsSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
Skin Health and Disease|June 1, 2026
Long-term postmarketing safety of psoriasis treatments on autoimmune disease risk: a 15-year nationwide cohort study in DenmarkSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
The Journal of Dermatological Treatment|February 17, 2018
Treatment changes in patients with psoriasis on etanercept or adalimumab: a retrospective chart reviewErica B Lee, Mina Amin, Alexander Egeberg, et al.
Pageof 34

Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
The British Journal of Dermatology|February 2, 2022
Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapyMette Gyldenløve, Howraman Meteran, Claus Zachariae, et al.
JAMA Dermatology|February 20, 2020
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-analysisSofie Vaengebjerg, Lone Skov, Alexander Egeberg, et al.
BMJ Open|March 23, 2019
Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohortAlexander Egeberg, Yuki M F Andersen, Jacob P Thyssen
Case Reports in Dermatology|April 1, 2021
Subtype-Specific Off-Label Treatment of RosaceaNita Wienholtz, Messoud Ashina, Jacob P Thyssen, et al.
Pharmacoepidemiology and Drug Safety|November 27, 2024
Post-Marketing Safety of Ustekinumab Based on 14-Year Follow-Up in Danish National Patient DataSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
International Journal of Pharmaceutical Compounding|March 21, 2020
Low-dose Naltrexone Therapy for PsoriasisLeonard B Weinstock, Jill Cottel, Lindsey Aldridge, et al.
Journal of the American Academy of Dermatology|July 31, 2020
Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysisNikolai Loft, Anne-Sofie Halling, Alexander Egeberg, et al.
Pharmacoepidemiology and Drug Safety|January 29, 2026
Comparing Different As-Treated Approaches: A Methodological Study Using Real-World Data on Psoriasis TreatmentsSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
Skin Health and Disease|June 1, 2026
Long-term postmarketing safety of psoriasis treatments on autoimmune disease risk: a 15-year nationwide cohort study in DenmarkSejun Kim, Andreas Jensen, Alexander Egeberg, et al.
The Journal of Dermatological Treatment|February 17, 2018
Treatment changes in patients with psoriasis on etanercept or adalimumab: a retrospective chart reviewErica B Lee, Mina Amin, Alexander Egeberg, et al.
Pageof 34